BioCentury on BioBusiness,
Tools & Techniques
Knockout mouse field growing
Monday, October 9, 2000
With the majority of human genes in hand and the focus now on
discerning the function of these genes, competition is growing in the functional genomics
arena. An example is the increasingly crowded knockout mouse market, as illustrated by
last week's partnership between Exelixis Inc., Artemis Pharmaceuticals GmbH and Sangamo BioSciences Inc. to combine their technologies in order to develop a new and faster method
for producing conditional knockouts.
As opposed to knockouts in which a gene is constitutively turned off,
conditional knockouts allow researchers to assess the effects of silencing a given gene at
various stages of development or disease progression. Also, the ability to turn a gene off
and back on can serve to mimic the action of a drug.
words displayed of
To read this article, you must be an Archives subscriber. Please choose one of the options below.
All contents Copyright © 1993-2016 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Whether you want an individual subscription or need a global group license, we have the products,
the experience and the customer support that biopharma executives, researchers, investors, service providers,
and industry stakeholders have trusted for nearly two decades.
Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.
Free Trial Subscription 4 Weeks of Access
BioCentury's Weekly Business Intelligence Journal
Get a 4-week free trial subscription to BioCentury.
Get 4 Weeks Free
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]